The FDA has given an update on its ongoing review of a possible link between GLP-1 agonist drugs used to treat diabetes and obesity and suicide ... Ozempic for diabetes and obesity therapy Wegovy ...

The suit comes amid recent studies showing a link between vision complications and people taking drugs containing semaglutide ...

Researchers say they have uncovered a link between semaglutide — the active ingredient in Ozempic and Wegovy — and sudden ... There are no effective treatments for NAION.

WEIGHT loss jabs could banish blues as well as bellies, a study claims. People taking the injections showed “significantly ...

Semaglutide and tirzepatide aid weight loss by mimicking gut hormones Ozempic, Wegovy, Mounjaro and Zepbound treat diabetes, support weight loss The weight loss drugs differ in FDA-approved uses ...

In 2022, the FDA opened the door, allowing teens 12 years and older to be prescribed Semaglutide, it’s the active ingredient in Ozempic and Wegovy. Semaglutide dispense rate increased by 594% ...

The findings come after reports of nasty side effects - including eye problems, infections and gastrointestinal disorders - ...

The lawsuits come amid several recent studies showing a link between vision complications and people taking drugs ...